Sage Journals: Discover world-class research

Abstract

Overactive bladder (OAB), which is characterized by the sudden and uncomfortable need to urinate with or without urinary leakage, is a challenging urological condition. The insufficient efficacy of current pharmacotherapies that uses antimuscarinic agents has increased the demand for novel long-term/stable therapeutic strategies. Here, we report the superior therapeutic efficacy of using mesenchymal stem cells (MSCs) for the treatment of OAB and a novel therapeutic mechanism that activates endogenous Oct4⁺ primitive stem cells. We induced OAB using bladder-outlet-obstruction (BOO) in a rat model and either administered a single transplantation of human adipose-derived MSCs or daily intravenous injections of solifenacin, an antimuscarinic agent, for 2 weeks. Within 2 weeks, both the MSC- and solifenacin-treated groups similarly demonstrated relief from BOO-induced detrusor overactivity, hypertrophic smooth muscle, and neurological injuries. In contrast with the solifenacin-treated groups, a single transplantation of MSCs improved most OAB parameters to normal levels within 4 weeks. Although the transplanted human MSCs were hardly engrafted into the damaged bladders, the bladder tissues transplanted with MSCs increased rat sequence-specific transcription of Oct4, Sox2, and Stella, which are surrogate markers for primitive pluripotent stem cells. In addition, MSCs enhanced the expression of several genes, responsible for stem cell trafficking, including SDF-1/CXCR4, HGF/cMet, PDGF/PDGFR, and VEGF/VEGFR signaling axis. These changes in gene expression were not observed in the solifenacin-treated group. Therefore, we suggest the novel mechanisms for the paracrine effect of MSCs as unleashing/mobilizing primitive endogenous stem cells, which could not only explain the long-term/stable therapeutic efficacy of MSCs, but also provide promising new therapies for the treatment of OAB.

Get full access to this article

View all access options for this article.

References

Michel

and Chapple

. (2009). Basic mechanisms of urgency: roles and benefits of pharmacotherapy. World J Urol, 27:705–709.

Steers

. (2002). Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol, 4 Suppl 4:S7–S18.

Chu

and Dmochowski

. (2006). Pathophysiology of overactive bladder. Am J Med, 119:3–8.

Andersson

K-E

. (2011). Antimuscarinic mechanisms and the overactive detrusor: an update. Eur Urol, 59:377–386.

Fowler

. (2002). Bladder afferents and their role in the overactive bladder. Urology, 59:37–42.

Chapple

and Roehrborn

. (2006). A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol, 49:651–659.

Austin

, Chacko

, DiSanto

, Canning

and Zderic

. (2004). A male murine model of partial bladder outlet obstruction reveals changes in detrusor morphology, contractility and Myosin isoform expression. J Urol, 172:1524–1528.

Peters

, Freeman

, Fernandez

, Shepard

, Wiederschain

and Moses

. (1997). Dysregulated proteolytic balance as the basis of excess extracellular matrix in fibrotic disease. Am J Physiol, 272:R1960–R1965.

Azadzoi

, Tarcan

, Kozlowski

, Krane

and Siroky

. (1999). Overactivity and structural changes in the chronically ischemic bladder. J Urol, 162:1768–1778.

10.

Abrams

and Andersson

K-E

. (2007). Muscarinic receptor antagonists for overactive bladder. BJU Int, 100:987–1006.

11.

Herbison

, Hay-Smith

, Ellis

and Moore

. (2003). Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ, 326:841–844.

12.

Chapple

, Khullar

, Gabriel

, Muston

, Bitoun

and Weinstein

. (2008). The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol, 54:543–562.

13.

Wezel

, Southgate

and Thomas

. (2011). Regenerative medicine in urology. BJU Int, 108:1046–1065.

14.

Zhao

, Zhang

, Jin

, Zhang

, Kong

, Xu

and Xiu

. (2011). Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model. Eur Urol, 59:155–163.

15.

Huang

Y-C

, Shindel

, Ning

, Lin

, Harraz

, Wang

, Garcia

, Lue

and Lin

C-S

. (2010). Adipose derived stem cells ameliorate hyperlipidemia associated detrusor overactivity in a rat model. J Urol, 183:1232–1240.

16.

Zhang

, Qiu

, Shindel

, Ning

, Ferretti

, Jin

, Lin

and Lue

. (2012). Adipose tissue-derived stem cells ameliorate diabetic bladder dysfunction in a type II diabetic rat model. Stem Cells Dev, 21:1391–1400.

17.

Montzka

and Heidenreich

. (2010). Application of mesenchymal stromal cells in urological diseases. BJU Int, 105:309–312.

18.

Cheng

and Yau

. (2008). Paracrine effects of cell transplantation: strategies to augment the efficacy of cell therapies. Semin Thorac Cardiovasc Surg, 20:94–101.

19.

Maltais

, Tremblay

, Perrault

and Ly

. (2010). The paracrine effect: pivotal mechanism in cell-based cardiac repair. J Cardiovasc Transl Res, 3:652–662.

20.

Gharaibeh

, Lavasani

, Cummins

and Huard

. (2011). Terminal differentiation is not a major determinant for the success of stem cell therapy—cross-talk between muscle-derived stem cells and host cells. Stem Cell Res Ther, 2:31

21.

Lin

C-S

. (2011). Stem cell therapy for the bladder—where do we stand?. J Urol, 185:779–780.

22.

Lin

C-S

and Lue

. (2011). Adipose-derived stem cells: characterization and application in urology. In: Adipose Stem Cells and Regenerative Medicine. Illouz

Y-G

and Sterodimas

, eds. Springer, Berlin, Heidelberg, Germany, pp 193–207.

23.

Lin

C-S

and Lue

. (2012). Adipose-derived stem cells: therapy through paracrine actions. In: Stem Cells and Cancer Stem Cells, Volume 4. Hayat

, ed. Springer, Dordrecht, Netherlands, pp 203–216.

24.

Shin

, Zuba-Surma

, Wu

, Ratajczak

, Wysoczynski

, Ratajczak

and Kucia

. (2009). Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct4(+) very small embryonic-like stem cells. Leukemia, 23:2042–2051.

25.

Corpechot

, Barbu

, Wendum

, Chignard

, Housset

, Poupon

and Rosmorduc

. (2002). Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis. Am J Pathol, 160:613–620.

26.

Morikawa

, Mabuchi

, Kubota

, Nagai

, Niibe

, Hiratsu

, Suzuki

, Miyauchi-Hara

, Nagoshi

, et al. (2009). Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med, 206:2483–2496.

27.

Phipps

, Xu

and Bellis

. (2012). Delivery of platelet-derived growth factor as a chemotactic factor for mesenchymal stem cells by bone-mimetic electrospun scaffolds. PLoS One, 7:e40831

28.

Ratajczak

, Kim

, Wojakowski

, Janowska-Wieczorek

, Kucia

and Ratajczak

. (2010). Innate immunity as orchestrator of stem cell mobilization. Leukemia, 24:1667–1675.

29.

Ratajczak

, Zuba-Surma

, Kucia

, Reca

, Wojakowski

and Ratajczak

. (2006). The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia, 20:1915–1924.

30.

Tsuzuki

, Fukumura

, Oosthuyse

, Koike

, Carmeliet

and Jain

. (2000). Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1{{alpha}} {→} hypoxia response element {→} VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res, 60:6248–6252.

31.

Ratajczak

, Reca

, Wysoczynski

, Yan

and Ratajczak

. (2006). Modulation of the SDF-1-CXCR4 axis by the third complement component (C3)—implications for trafficking of CXCR4+stem cells. Exp Hematol, 34:986–995.

32.

Ratajczak

, Lee

, Wysoczynski

, Wan

, Marlicz

, Laughlin

, Kucia

, Janowska-Wieczorek

and Ratajczak

. (2010). Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. Leukemia, 24:976–985.

33.

Kim

, Wu

, Wysoczynski

, Abdel-Latif

, Sunkara

, Morris

, Kucia

, Ratajczak

and Ratajczak

. (2012). Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: a novel role for bioactive lipids and soluble C5b-C9 as homing factors. Leukemia, 26:106–116.

34.

Ball

, Shuttleworth

and Kielty

. (2010). Platelet-derived growth factor receptors regulate mesenchymal stem cell fate: implications for neovascularization. Exp Opin Biol Ther, 10:57–71.

35.

Ratajczak

, Machalinski

, Wojakowski

, Ratajczak

and Kucia

. (2007). A hypothesis for an embryonic origin of pluripotent Oct-4(+) stem cells in adult bone marrow and other tissues. Leukemia, 21:860–867.

36.

Kucia

, Reca

, Campbell

, Zuba-Surma

, Majka

, Ratajczak

and Ratajczak

. (2006). A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4(+) stem cells identified in adult bone marrow. Leukemia, 20:857–869.

37.

Wojakowski

, Tendera

, Kucia

, Zuba-Surma

, Paczkowska

, Ciosek

, Halasa

, Krol

, Kazmierski

, et al. (2009). Mobilization of bone marrow-derived Oct-4(+) SSEA-4(+) very small embryonic-like stem cells in patients with acute myocardial infarction. J Am Coll Cardiol, 53:1–9.

38.

Lin

, Lin

and Lue

. (2012). Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev, 21:2770–2778.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.06 MB

0.28 MB

0.23 MB

0.06 MB

The Paracrine Effects of Mesenchymal Stem Cells Stimulate the Regeneration Capacity of Endogenous Stem Cells in the Repair of a Bladder-Outlet-Obstruction-Induced Overactive Bladder

Abstract

Get full access to this article

References

Supplementary Material